Skip to main content
. 2023 Aug 2;29(10):1229–1239. doi: 10.1177/13524585231188625

Figure 3.

Figure 3.

Longitudinal dynamics of serum GFAP levels and serum NfL levels. A significant decrease in serum GFAP levels was seen in the first 3 months, and a significant decrease of serum NfL levels was seen in the first 3 months (with its nadir at 1 year of treatment). 22 Serum GFAP and NfL correlated at baseline and last follow-up.

GFAP: glial fibrillary acidic protein; NfL: neurofilament light; BL: baseline; 3M: 3 months after baseline; 12M: 12 months after baseline; 24M: 24 months after baseline; LFU: last sample follow-up.